Filing Details

Accession Number:
0001562180-21-007867
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-12-22 21:51:33
Reporting Period:
2021-12-20
Accepted Time:
2021-12-22 21:51:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1689813 Biohaven Pharmaceutical Holding Co Ltd. BHVN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1226675 P Julia Gregory C/O Biohaven Pharmaceuticals, Inc.
215 Church Street
New Haven CT 06510
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2021-12-20 12,000 $23.63 12,000 No 4 M Direct
Common Shares Disposition 2021-12-20 12,000 $125.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Employee Stock Option (Right to Buy) Disposition 2021-12-20 12,000 $0.00 12,000 $23.63
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2027-08-01 No 4 M Direct
Footnotes
  1. This exercise and sale was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
  2. This option grant was made pursuant to the Issuer's non-employee director compensation policy. The option, representing a right to purchase a total of 36,000 shares, was granted on August 2, 2017, and vested in three equal installments on August 2, 2018, 2019 and 2020.